Sana Biotechnology SANA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's operating lease right-of-use assets in other assets?
- Sana Biotechnology (SANA) reported operating lease right-of-use assets in other assets of $35.85M in Q1 2026.
- How has Sana Biotechnology's operating lease right-of-use assets in other assets changed year-over-year?
- Sana Biotechnology's operating lease right-of-use assets in other assets decreased by 34.6% year-over-year, from $54.84M to $35.85M.
- What is the long-term trend for Sana Biotechnology's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Sana Biotechnology's operating lease right-of-use assets in other assets has grown at a -9.5% compound annual growth rate (CAGR), from $63.17M to $38.31M.